Petrelis Files

FOIA Request for Disclosure Forms of NIH HIV Drug Panel

[The year is coming to a close, so this FOIA request is my last one of 2006.

Some AIDS activists familiar with the NIH HIV drug Panel may wonder why I'm filing this FOIA when the Panel members, at the end of their treatment recommendations guidelines, dislosure basic conflict and financial information.

The reason for the request is to learn what exactly the members put on their forms for NIAID and compare it with what is released in the guidelines. I doubt that it is simply a list of drug companies who've showered the members with grants and honoraria, but I may be wrong.

NIAID releasing the actual forms will do much to increase transparency over the Panel and the forces that influence it.]


December 29, 2006

Karin Lohman, Acting Chief
Freedom of Information Office
National Institute of Allergy and Infectious Diseases
Bethesda, MD

Dear Ms. Lohman:

Pursuant to the full provisions of the Freedom of Information Act and all its revisions, I hereby request in electronic format the most recent financial disclosure forms and conflict of interest declarations, during calendar years 2005 and 2006, by all members of the Panel on Clinical Practices for Treatment of HIV Infection, and the Panel's support staff and advisors to the body.

Here is the list of individuals whose disclosure forms I am requesting:

1. John G. Bartlett (co-chair), Johns Hopkins University, Baltimore, MD;

2. H. Clifford Lane (co-chair), National Institutes of Health, Bethesda, MD

3. Jean Anderson, Johns Hopkins University, Baltimore, MD;

4. A. Cornelius Baker, Washington, DC;

5. Samuel A. Bozzette, San Diego Veterans Affairs Medical Center, San Diego, CA;

6. Charles Carpenter, Brown Medical School, Providence, RI;

7. Lawrence Deyton, Department of Veterans Affairs, Washington, DC;

8. Mark Dybul, Office of Global AIDS Coordinator, Department of State, Washington, DC;

9. Wafaa El-Sadr, Harlem Hospital Center & Columbia University, New York, NY;

10. Courtney V. Fletcher, University of Colorado Health Sciences Center, Denver, CO;

11. Gregg Gonsalves, Gay Men's Health Crisis, New York, NY;

12. Eric P. Goosby, Pangaea Global AIDS Foundation, San Francisco, CA;

13. Fred Gordin, Veterans Affairs Medical Center, Washington, DC;
14. Roy M. Gulick, Weill Medical College of Cornell University, New York, NY;

15. Mark Harrington, Treatment Action Group, New York, NY;

16. Martin S. Hirsch, Massachusetts General Hospital and Harvard University, Boston, MA;

17. John W. Mellors, University of Pittsburgh, Pittsburgh, PA;

18. James Neaton, University of Minnesota, Minneapolis, MN;

19. Heidi Nass, University of Wisconsin, Madison, WI;

20. James Oleske, University of Medicine and Dentistry of New Jersey, Newark, NJ;

21. Robert T. Schooley, University of California, San Diego, La Jolla, CA;

22. Renslow Sherer, Project HOPE, Midland, VA;

23. Stephen A. Spector, University of California San Diego, La Jolla, CA;

24. Sharilyn K. Stanley, Texas House of Representatives, Austin, TX;

25. Paul Volberding, University of California San Franscisco & VA Medical Center, San Francisco, CA;

26. Suzanne Willard, Drexel University, Philadelphia, PA

27. Debra Birnkrant, Food and Drug Administration;

28. Victoria Cargill-Swiren, National Institutes of Health;

29. Laura Cheever, Health Resources and Services Administration;

30. Mark Dybul, National Institutes of Health (Co-Executive Secretary);

31. Jonathan Kaplan, Centers for Disease Control and Prevention;

32. Henry Masur, National Institutes of Health;

33. Lynne Mofenson, National Institutes of Health;

34. Jeffrey Murray, Food and Drug Administration;

35. Alice Pau, National Institutes of Health (Executive Secretary)

If at all possible, please provide me with the requested forms and declarations for the Panel members and advisors in digital format via email.

On the other hand, if the documents are not available for transmission via email or exist only on paper and can't easily be put into PDF formatting, you can send the documents to mm through my snail mail address.

No matter what the format is for the documents, they should be readily available for quick release in response to this FOIA request, as NIAID requires such disclosure forms are regularly updated.

Should you have any questions or need clarification, contact me at 415-621-xxxx.

Sincerely yours,
Michael Petrelis